Kimmtrak (tebentafusp-tebn)
Customize your policy alerts
Sign up for Anthem Policy CC-0211 alerts
Get alerted when Policy CC-0211 changes without checking for updates manually.
Monitor payer policy activity
Clinical criteria governing prior authorization and medical necessity determinations for Kimmtrak (tebentafusp-tebn) for treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma under the medical benefit.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.